The softness of tumour-cell-derived microparticles regulates their drug-delivery efficiency

Nat Biomed Eng. 2019 Sep;3(9):729-740. doi: 10.1038/s41551-019-0405-4. Epub 2019 May 20.

Abstract

Extracellular microparticles (MPs) can function as drug-delivery vehicles for anticancer drugs. Here, we show that the softness of MPs derived from tumour-repopulating cells (TRCs) isolated from three-dimensional fibrin gels enhances the MPs' drug-delivery efficiency. We found that, compared with MPs derived from tumour cells cultured in conventional tissue-culture plastic, TRC-derived MPs intravenously injected in tumour-xenograft-bearing mice showed enhanced accumulation in tumour tissues, enhanced blood-vessel crossing and penetration into tumour parenchyma, and preferential uptake by highly tumorigenic TRCs. We also show that the cytoskeleton-related protein cytospin-A plays a critical role in the regulation of TRC-derived MP softness. The modulation of the mechanical properties of TRC-derived MPs could aid the efficiency of delivery of anticancer drugs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Apoptosis
  • Blood Vessels
  • Cell Line, Tumor
  • Cell Survival
  • Cell-Derived Microparticles / chemistry*
  • Cytoskeleton
  • Disease Models, Animal
  • Drug Delivery Systems / methods*
  • Female
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Parenchymal Tissue / blood supply
  • Parenchymal Tissue / drug effects
  • Phosphoproteins / metabolism
  • RAW 264.7 Cells
  • Xenograft Model Antitumor Assays

Substances

  • Antineoplastic Agents
  • Phosphoproteins